Stereotaxis Announces That Physicians At The Hospital Da Luz In Lisbon, Portugal Have Successfully Treated The First Patients Using The Advanced Genesis Robotic Magnetic Navigation System
Stereotaxis Announces That Physicians At The Hospital Da Luz In Lisbon, Portugal Have Successfully Treated The First Patients Using The Advanced Genesis Robotic Magnetic Navigation System
Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at the Hospital da Luz in Lisbon, Portugal have successfully treated the first patients using the advanced Genesis Robotic Magnetic Navigation (RMN) System.
Stereotaxis（紐約證券交易所代碼：STXS）是微創血管內介入手術機器人領域的先驅和全球領導者，今天宣佈，葡萄牙里斯本達盧斯醫院的醫生已使用先進的創世紀機器人磁導航（RMN）系統成功治療了首批患者。
"We are excited to be at the forefront of technology and patient care by introducing the new Genesis System at Hospital da Luz," said Prof. Pedro Adragão, Cardiac Electrophysiologist at Hospital da Luz. "Robotics allows us to treat patients with effective individualized therapy and the highest focus on safety. We are pleased to offer this high-level care to all our patients, including those with the most complex arrhythmia. We also are pleased to continue advancing this important technology for the benefit of patients and medical progress."
達盧斯醫院心臟電生理學家佩德羅·阿德拉加奧教授說：「我們很高興能在達盧斯醫院推出新的創世紀系統，站在技術和患者護理的最前沿。」「機器人技術使我們能夠通過有效的個性化治療和對安全性的高度關注來治療患者。我們很高興爲所有患者提供這種高水平的護理，包括心律失常最複雜的患者。我們也很高興繼續推進這項重要技術，以造福患者和醫學進步。」
